IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i12p7132-d835910.html
   My bibliography  Save this article

Risk Measurement of Perinatal and Neonatal Morbidity Characteristics and Applicability of GAIA Case Definitions: Results and Lessons Learnt of a Hospital-Based Prospective Cohort Study in the Valencia Region (2019–2020)

Author

Listed:
  • Antonio Carmona

    (Vaccines Research Department, Fundación Para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Fisabio), Av. de Catalunya, 21, 46020 Valencia, Spain)

  • María Latorre Tejerina

    (Department of Pediatrics, Hospital General Universitario de Castellón, Avinguda de Benicàssim, 128, 12004 Castelló de la Plana, Spain)

  • Alicia Martínez Sebastián

    (Department of Pediatrics, Hospital Universitario Doctor Peset, Av. de Gaspar Aguilar, 90, 46017 Valencia, Spain)

  • Dafina Dobreva

    (P95 Pharmacovigilance and Epidemiology, 3010 Leuven, Belgium)

  • Cristina P. Jurca

    (Department of Pediatrics, Hospital General Universitario de Castellón, Avinguda de Benicàssim, 128, 12004 Castelló de la Plana, Spain)

  • Sergio Huerta Barberá

    (Department of Pediatrics, Hospital General Universitario de Castellón, Avinguda de Benicàssim, 128, 12004 Castelló de la Plana, Spain)

  • Vicente Bernat Montoya

    (Department of Pediatrics, Hospital General Universitario de Castellón, Avinguda de Benicàssim, 128, 12004 Castelló de la Plana, Spain)

  • Mercedes Aristoy Zabaleta

    (Department of Pediatrics, Hospital General Universitario de Castellón, Avinguda de Benicàssim, 128, 12004 Castelló de la Plana, Spain)

  • Ana Pineda Caplliure

    (Department of Pediatrics, Hospital Universitario Doctor Peset, Av. de Gaspar Aguilar, 90, 46017 Valencia, Spain)

  • Beatriz Mansilla Roig

    (Department of Pediatrics, Hospital Universitario Doctor Peset, Av. de Gaspar Aguilar, 90, 46017 Valencia, Spain)

  • María Navío Anaya

    (Department of Pediatrics, Hospital Universitario Doctor Peset, Av. de Gaspar Aguilar, 90, 46017 Valencia, Spain)

  • Ricardo Tosca-Segura

    (Department of Pediatrics, Hospital General Universitario de Castellón, Avinguda de Benicàssim, 128, 12004 Castelló de la Plana, Spain)

  • Miguel Tortajada-Girbés

    (Department of Pediatrics, Hospital Universitario Doctor Peset, Av. de Gaspar Aguilar, 90, 46017 Valencia, Spain)

  • Javier Díez-Domingo

    (Vaccines Research Department, Fundación Para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Fisabio), Av. de Catalunya, 21, 46020 Valencia, Spain
    Universidad Católica de Valencia San Vicente Mártir, Carrer de Quevedo, 2, 46001 Valencia, Spain)

  • Alejandro Orrico-Sánchez

    (Vaccines Research Department, Fundación Para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Fisabio), Av. de Catalunya, 21, 46020 Valencia, Spain
    Universidad Católica de Valencia San Vicente Mártir, Carrer de Quevedo, 2, 46001 Valencia, Spain)

Abstract

Post-marketing safety surveillance of new vaccines aimed to be administered during pregnancy is crucial to orchestrate efficient adverse events evaluation. This is of special relevance in the current landscape of new vaccines being introduced in the pregnant women population, and particularly due to the recent administration of COVID-19 vaccines in pregnant women. This multi-center prospective cohort study, nested within the WHO-Global Vaccine Safety-MCC study, involved two hospitals in the Valencia region. Hereby, the incidence rates of seven perinatal and neonatal outcomes in the Valencia region are presented. The pooled data analysis of the two Valencian hospitals allowed the estimation of incidence rates in the Valencia Region (per 1000 live births): 86.7 for low birth weight, 78.2 for preterm birth, 58.8 for small for gestational age, 13 for congenital microcephaly, 0.4 for stillbirth, 1.2 for neonatal death and 6.5 for neonatal infection. These figures are in line with what is expected from a high-income country and the previously reported rates for Spain and Europe, except for the significantly increased rate for congenital microcephaly. Regarding the data for maternal immunization, the vaccination status was collected for 94.4% of the screened pregnant women, highlighting the high quality of the Valencian Vaccine Registry. The study also assessed the Valencian hospitals’ capacity for identifying and collecting data on maternal immunization status, as well as the applicability of the GAIA definitions to the identified outcomes.

Suggested Citation

  • Antonio Carmona & María Latorre Tejerina & Alicia Martínez Sebastián & Dafina Dobreva & Cristina P. Jurca & Sergio Huerta Barberá & Vicente Bernat Montoya & Mercedes Aristoy Zabaleta & Ana Pineda Capl, 2022. "Risk Measurement of Perinatal and Neonatal Morbidity Characteristics and Applicability of GAIA Case Definitions: Results and Lessons Learnt of a Hospital-Based Prospective Cohort Study in the Valencia," IJERPH, MDPI, vol. 19(12), pages 1-15, June.
  • Handle: RePEc:gam:jijerp:v:19:y:2022:i:12:p:7132-:d:835910
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/12/7132/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/19/12/7132/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:12:p:7132-:d:835910. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.